To investigate the influential factors related to developing LNE in RA patients, we found CRP and ACPA to be possible risk factors, which is consistent with the view reported by van Baarsen et al. that positivity for RA and/or ACPA was observed in early arthritis patients and in autoantibody-negative healthy controls [38]. The gene discussed is PRTN3; the disease is rheumatoid arthritis.